Patents by Inventor David Francis Corbett

David Francis Corbett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40
    Patent number: 7834013
    Abstract: The present invention relates generally to novel therapeutic compounds and more particularly to novel compounds, their use as GPR40 agonists, processes for their manufacture, and intermediates useful in their preparation.
    Type: Grant
    Filed: November 15, 2004
    Date of Patent: November 16, 2010
    Assignee: GlaxoSmithKline LLC
    Inventors: David Francis Corbett, Kate Anna Dwornik, Dulce Maria Garrido, Stephen Carl McKeown, Wendy Yoon Mills, Andrew James Peat, Terrence Lee Smalley, Jr.
  • NOVEL M3 MUSCARINIC ACETYLCHOINE RECEPTOR ANTAGONISTS
    Publication number: 20090253908
    Abstract: Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.
    Type: Application
    Filed: March 11, 2005
    Publication date: October 8, 2009
    Inventors: Brian W. Budzik, Anthony W. J. Cooper, David Francis Corbett, Jian Jin, Dramane I. Laine, Yonghui Wang, Michael Lee Moore, Ralph A. Rivero, Dongchuan Shi, Feng Wang, Haibo Xie, Chongjie Zhu
  • AMINOPHENYLCYCLOPROPYL CARBOXYLIC ACIDS AND DERIVATIVES AS AGONISTS TO GPR40
    Publication number: 20090105257
    Abstract: The present invention relates generally to novel therapeutic compounds and more particularly to novel compounds, their use as GPR40 agonists, processes for their manufacture, and intermediates useful in their preparation.
    Type: Application
    Filed: November 15, 2004
    Publication date: April 23, 2009
    Inventors: David Francis Corbett, Kate Anna Dwornik, Dulce Maria Garrido, Stephen Carl McKeown, Wendy Yoon Mills, Andrew James Peat, Terrence Lee Smalley, JR.
  • Phenyl derivatives useful as endothelin receptor antagonists
    Patent number: 6147111
    Abstract: Novel phenyl derivatives which are useful as endothelin receptor antagonists.
    Type: Grant
    Filed: January 8, 1999
    Date of Patent: November 14, 2000
    Assignees: SmithKline Beecham p.l.c., SmithKline Beecham Corporation
    Inventors: Jia-Ning Xiang, David Timothy MacPherson, David Francis Corbett, John Duncan Elliott